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OBJECTIVE: To estimate the length of stay (LOS) and total
charges among inpatients with rheumatoid arthritis (RA) based
on patient- and hospital- related characteristics. METHODS: A
retrospective analysis was conducted using a 20% sample from
the 2004 Nationwide Inpatient Sample (NIS) of the Healthcare
Cost and Utilization Project (HCUP) data. NIS is an all-payer
inpatient care database that contains hospital discharge data
from a national sample of more than 1,000 hospitals. The 2004
NIS of the HCUP data was used to extract individuals with RA
(primary diagnosis using ICD-9 code 714.0). Descriptive analysis
was conducted to examine the differences in RA-related LOS and
total charges by patient-related (age, race, gender, payer status,
patient location, and median household income) and hospital-
related (bed-size, geographic region, location, and teaching
status) characteristics. Multiple regression was conducted to
identify patient- and hospital-related predictors of LOS and
charges among inpatients with RA. RESULTS: A total of 655
individuals with RA were extracted. The mean age was 61.92
years and the patients were predominantly female (79.3%) and
white (68.8%). In addition, around 50% of these patients were
located in large metro areas. A majority of hospitalizations
occurred in the Southern region (34.8%) of the U.S in hospitals
that had a large bed-size (57.3%). The mean LOS for patients
with RA was 4.24 days and mean total charges were $25,852.
The payer variable ‘private insurance’ was found to be a predic-
tor of LOS while the predictors for charges included race (His-
panics), age (61–70 years), and geographic location (Western
region). CONCLUSION: Inpatients LOS and charges are high in
RA. Successful interventions that take into account important
RA-related patient and hospital characteristics could result in
improved health outcomes and substantial cost savings in this
population.
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OBJECTIVE: To evaluate the relationship between out-of-pocket
(OOP) expenses for medication and clinical outcomes in rheu-
matoid arthritis (RA) patients. METHODS: A 2006 Rheumatoid
Arthritis Patient Survey data (wave 7) was analyzed. Adult RA
patients completed an online questionnaire regarding their RA
disease status, signs and symptoms, quality of life as measured by
physical (PCS) mental component scores (MCS) of Short Form-8
(SF-8), and work productivity loss measured by Work Produc-
tivity and Activity Impairment (WPAI). Comparisons were made
between two groups: patients reporting per-month OOP  $100
and OOP < $00. Multivariate analyses were performed to
control for confounding factors, including age, gender, duration
and severity of RA, signs, and symptoms. RESULTS: Of the 2000
respondents, 77.4% were female and the average age was 51.6
years. The mean per-month OOP was $95.75 for all medications.
Compared with patients reporting <$0 OOP (N = 1376, 68.8%),
the OOP  $100 group (N = 624, 31.2%) had signiﬁcantly
worse patient-reported clinical measures and outcomes (all
P-values <0.0001), including pain scores (6.20 vs. 5.39), morning
stiffness (6.32 vs. 5.53), fatigue (6.36 vs. 5.11), PCS (34.66 vs.
38.37), MCS (41.21 vs. 43.79), work productivity loss of WPAI
(35.43% vs. 28.14%). After adjusting the confounding factors
(age, gender, % of prescription by rheumatologist, severity and
years with RA), higher OOP is positively related to pain,
morning stiffness, fatigue, WPAI and negatively related to PCS
score. CONCLUSION: In addition to safety and efﬁcacy, cost or
OOP is an important factor in the decision of the RA treatment.
This study indicates that higher OOP is negatively related to the
clinical outcomes (including signs and symptoms, quality of life
and work and productivity loss). It is recommended that more
research be conducted to evaluate the impact of co-payments and
OOP on the economic, clinical, and humanistic outcomes in the
treatment of RA.
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OBJECTIVE: To investigate the trends in length of stay (LOS),
total charges, and principal procedures for rheumatoid arthritis-
related (RA) hospitalizations for 2002–2004. METHODS: A
retrospective analysis was conducted using a 20% sample from
2004 Nationwide Inpatient Sample (NIS) of the Healthcare Cost
and Utilization Project (HCUP) data. NIS is an all-payer inpa-
tient care database that contains hospital discharge data from a
national sample of more than 1000 hospitals. Inpatient data
from 2002 through 2004 were obtained from the NIS datasets.
Individuals with RA (primary diagnosis using ICD-9 code 714.0)
were extracted from the datasets. A descriptive analysis was
conducted to assess the trends in LOS, total charges, and princi-
pal procedures. RESULTS: A total number of 744 hospitalized
RA cases were observed in 2002, 612 cases in 2003 and 655
cases in 2004. LOS as well as total charges showed an increasing
trend from 2002 through 2004. The mean LOS was 3.99 days in
2002, 4.22 days in 2003, and 4.24 days in 2004; whereas the
mean total charges were $19,712 in 2002, $24,724 in 2003, and
$25,852 in 2004. Around 72%, 74%, and 73.4% patients had
undergone some surgical procedures in years 2002, 2003 and
2004, respectively. Total knee replacement (TKR) and total hip
replacement (THR) comprised the procedures conducted most
often for all three years. TKR was conducted on 18.07% patients
in 2002, 18.64% in 2003 and 21.29% in 2004. CONCLUSION:
There is a dearth of data on trends in LOS and total charges for
RA patients in the literature. Even though the number of hospi-
talizations for RA is decreasing, there is an increasing trend in the
average LOS and total charges. The increase in surgical proce-
dures over the time period could be a contributing factor to the
longer LOS and higher total charges.
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OBJECTIVE: Research sponsored by the pharmaceutical indus-
try is often assumed to be more likely to report favorable cost-
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